Bangkok Workshop on Leprosy Research. Treatment of reactions and nerve damage.
Naafs
B
B
Department of Dermatology and Venereology, University Hospital, Leiden, The Netherlands.
D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000627:therapeutic use; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage / Q000627:therapeutic use; D002991:Clofazimine / Q000008:administration & dosage / Q000627:therapeutic use; D016572:Cyclosporine / Q000008:administration & dosage / Q000627:therapeutic use; D004334:Drug Administration Schedule; D004893:Erythema Nodosum / Q000188:drug therapy* / Q000276:immunology / Q000473:pathology; D006801:Humans; D006968:Hypersensitivity, Delayed / Q000188:drug therapy; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000627:therapeutic use; D007917:Leprostatic Agents / Q000008:administration & dosage / Q000627:therapeutic use; D007918:Leprosy / Q000188:drug therapy* / Q000276:immunology / Q000473:pathology; D015440:Leprosy, Lepromatous / Q000188:drug therapy* / Q000276:immunology / Q000473:pathology; D010523:Peripheral Nervous System Diseases / Q000188:drug therapy* / Q000473:pathology / Q000503:physiopathology; D011239:Prednisolone / Q000008:administration & dosage / Q000627:therapeutic use; D011241:Prednisone / Q000008:administration & dosage / Q000627:therapeutic use; D013792:Thalidomide / Q000008:administration & dosage / Q000627:therapeutic use
D000893:Anti-Inflammatory Agents; D000894:Anti-Inflammatory Agents, Non-Steroidal; D007166:Immunosuppressive Agents; D007917:Leprostatic Agents; D013792:Thalidomide; D016572:Cyclosporine; D011239:Prednisolone; D002991:Clofazimine; D011241:Prednisone